Trivium Point Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-336	Closed	-$270K	–	349
2024 Q3	$270K	Buy	336 +127	+61%	+$102K	0.04%	294
2024 Q2	$220K	Buy	+209	New	+$220K	0.03%	286